steffimycin has been researched along with Mycobacterium avium-intracellulare Infection in 1 studies
*Mycobacterium avium-intracellulare Infection: A nontuberculous infection when occurring in humans. It is characterized by pulmonary disease, lymphadenitis in children, and systemic disease in AIDS patients. Mycobacterium avium-intracellulare infection of birds and swine results in tuberculosis. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kanamoto, A; Koyama, N; Shigeno, S; Tomoda, H | 1 |
1 other study(ies) available for steffimycin and Mycobacterium avium-intracellulare Infection
| Article | Year |
|---|---|
Steffimycin E, a new anti-mycobacterial agent against Mycobacterium avium complex, produced by Streptomyces sp. OPMA02852.
Topics: Anthracyclines; Antitubercular Agents; Cell Line, Tumor; HeLa Cells; Humans; Mycobacterium avium; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Streptomyces | 2020 |